Lishan Aklog, M.D. Chairman & Chief Executive Officer PAVmed Inc. One Grand Central Place, Suite 4600 New York, NY 10165 Dear Dr. Aklog:Placement Agent Agreement • December 18th, 2020 • PAVmed Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledDecember 18th, 2020 Company Industry JurisdictionThis letter (the “Agreement”) constitutes the agreement between Maxim Group LLC (“Maxim”) Lake Street Capital Markets LLC (“Lake Street”, and together with Maxim, the “Placement Agents”) and PAVmed Inc. (the “Company”), pursuant to which Maxim shall serve as the lead exclusive placement agent and Lake Street shall serve as co-placement agent for the Company, on a “reasonable best efforts” basis, in connection with the proposed placement (the “Placement”) of registered shares (the “Shares” or the “Securities”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”). The terms of the Placement and the Securities shall be mutually agreed upon by the Company and the purchasers (each, a “Purchaser” and collectively, the “Purchasers”) and nothing herein constitutes that the Placement Agents would have the power or authority to bind the Company or any Purchaser or an obligation for the Company to issue any Securities or complete the Placement. This Agreement and the doc
Lishan Aklog, M.D. Chairman & Chief Executive Officer PAVmed Inc. One Grand Central Place, Suite 4600 New York, NY 10165 Dear Dr. Aklog:Placement Agent Agreement • December 11th, 2020 • PAVmed Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledDecember 11th, 2020 Company Industry JurisdictionThis letter (the “Agreement”) constitutes the agreement between Maxim Group LLC (“Maxim”) Lake Street Capital Markets LLC (“Lake Street”, and together with Maxim, the “Placement Agents”) and PAVmed Inc. (the “Company”), pursuant to which Maxim shall serve as the lead exclusive placement agent and Lake Street shall serve as co-placement agent for the Company, on a “reasonable best efforts” basis, in connection with the proposed placement (the “Placement”) of registered shares (the “Shares” or the “Securities”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”). The terms of the Placement and the Securities shall be mutually agreed upon by the Company and the purchasers (each, a “Purchaser” and collectively, the “Purchasers”) and nothing herein constitutes that the Placement Agents would have the power or authority to bind the Company or any Purchaser or an obligation for the Company to issue any Securities or complete the Placement. This Agreement and the doc